These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 12794530

  • 21. All children with malignant rhabdoid tumors should be treated initially with intensive chemotherapy.
    Hernández-Marqués C, Lassaletta A, Cormenzana M, García-Esparza E, Madero-López L.
    Pediatr Hematol Oncol; 2015 Apr; 32(3):193-8. PubMed ID: 24852450
    [Abstract] [Full Text] [Related]

  • 22. Multimodal Management of Congenital Orbital Malignant Rhabdoid Tumor: Review of Literature and Report of a Rare Case.
    Biswas A, Kumar R, Bakhshi S, Sen S, Sharma MC.
    J Pediatr Hematol Oncol; 2020 Apr; 42(3):228-233. PubMed ID: 30608492
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 27. Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal tumour study group.
    van den Heuvel-Eibrink MM, van Tinteren H, Rehorst H, Coulombe A, Patte C, de Camargo B, de Kraker J, Leuschner I, Lugtenberg R, Pritchard-Jones K, Sandstedt B, Spreafico F, Graf N, Vujanic GM.
    Pediatr Blood Cancer; 2011 May; 56(5):733-7. PubMed ID: 21370404
    [Abstract] [Full Text] [Related]

  • 28. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
    Adam Z, Rehák Z, Koukalová R, Szturz P, Krejčí M, Pour L, Zahradová L, Moulis M, Kodet R, Nebeský T, Brejcha M, Adamová Z, Hájek R, Mayer J.
    Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
    [Abstract] [Full Text] [Related]

  • 29. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
    Margolin K, Doroshow JH, Ahn C, Hamasaki V, Leong L, Morgan R, Raschko J, Shibata S, Somlo G, Tetef M.
    J Clin Oncol; 1996 Oct; 14(10):2631-7. PubMed ID: 8874321
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Treatment of CNS malignant rhabdoid tumors.
    Ronghe MD, Moss TH, Lowis SP.
    Pediatr Blood Cancer; 2004 Mar; 42(3):254-60. PubMed ID: 14752863
    [Abstract] [Full Text] [Related]

  • 32. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005.
    Brennan B, De Salvo GL, Orbach D, De Paoli A, Kelsey A, Mudry P, Francotte N, Van Noesel M, Bisogno G, Casanova M, Ferrari A.
    Eur J Cancer; 2016 Jun; 60():69-82. PubMed ID: 27082136
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.
    Avramova B, Jordanova M, Michailov G, Konstantinov D, Christosova I, Bobev D.
    J BUON; 2006 Jun; 11(4):433-8. PubMed ID: 17309174
    [Abstract] [Full Text] [Related]

  • 36. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
    Mappa S, Marturano E, Licata G, Frezzato M, Frungillo N, Ilariucci F, Stelitano C, Ferrari A, Sorarù M, Vianello F, Baldini L, Proserpio I, Foppoli M, Assanelli A, Reni M, Caligaris-Cappio F, Ferreri AJ.
    Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
    [Abstract] [Full Text] [Related]

  • 37. Where to next with extracranial rhabdoid tumours in children.
    Brennan BM, Foot AB, Stiller C, Kelsey A, Vujanic G, Grundy R, Pritchard Jones K, United Kingdom Children's Cancer Study Group (UKCCSG).
    Eur J Cancer; 2004 Mar; 40(4):624-6. PubMed ID: 14962734
    [No Abstract] [Full Text] [Related]

  • 38. Successful outcome with tandem myeloablative chemotherapy and autologous peripheral blood stem cell transplants in a patient with atypical teratoid/rhabdoid tumor of the central nervous system.
    Gidwani P, Levy A, Goodrich J, Weidenheim K, Kolb EA.
    J Neurooncol; 2008 Jun; 88(2):211-5. PubMed ID: 18317689
    [Abstract] [Full Text] [Related]

  • 39. Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.
    Mangel J, Buckstein R, Imrie K, Spaner D, Crump M, Tompkins K, Reis M, Perez-Ordonez B, Deodhare S, Romans R, Pennell N, Robinson JB, Hewitt K, Richardson P, Lima A, Pavlin P, Berinstein NL.
    Semin Oncol; 2002 Feb; 29(1 Suppl 2):56-69. PubMed ID: 11842390
    [Abstract] [Full Text] [Related]

  • 40. Primary pineal rhabdomyosarcoma successfully treated by high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation: case report.
    Ishi Y, Yamaguchi S, Iguchi A, Cho Y, Ohshima J, Hatanaka KC, Takakuwa E, Kobayashi H, Terasaka S, Houkin K.
    J Neurosurg Pediatr; 2016 Jul; 18(1):41-5. PubMed ID: 26942266
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.